Ferroptosis landscape in prostate cancer from molecular and metabolic perspective.

Tianjin institute of Urology, The Second Hospital of Tianjin Medical University, 300211, Tianjin, China. School of Future Technology, Xi'an Jiaotong University, 710049, Xi'an, Shaanxi, China. Department of Urology, Tangdu Hospital, The Air Force Military Medical University, Xi'an, Shaanxi, China. Department of Radiology, Tianjin Medical University Second Hospital, Tianjin, China. Tianjin institute of Urology, The Second Hospital of Tianjin Medical University, 300211, Tianjin, China. jiangning@tmu.edu.cn.

Cell death discovery. 2023;(1):128

Abstract

Prostate cancer is a major disease that threatens men's health. Its rapid progression, easy metastasis, and late castration resistance have brought obstacles to treatment. It is necessary to find new effective anticancer methods. Ferroptosis is a novel iron-dependent programmed cell death that plays a role in various cancers. Understanding how ferroptosis is regulated in prostate cancer will help us to use it as a new way to kill cancer cells. In this review, we summarize the regulation and role of ferroptosis in prostate cancer and the relationship with AR from the perspective of metabolism and molecular pathways. We also discuss the feasibility of ferroptosis in prostate cancer treatment and describe current limitations and prospects, providing a reference for future research and clinical application of ferroptosis.

Methodological quality

Publication Type : Review

Metadata